Cosmo Pharmaceuticals N.V. (CMOPF)

USD 73.5

(0.0%)

Eps Summary of Cosmo Pharmaceuticals N.V.

Cosmo Pharmaceuticals N.V.'s latest annual eps in 2023 was -0.31 EUR , down -91.54% from previous year.
Cosmo Pharmaceuticals N.V.'s latest quarterly eps in 2024 Q1 was 2.54 USD , up 1275.0% from previous quarter.
Cosmo Pharmaceuticals N.V. reported an annual eps of 1.14 USD in 2022, down -25.0% from previous year.
Cosmo Pharmaceuticals N.V. reported an annual eps of 1.52 USD in 2021, up 330.3% from previous year.
Cosmo Pharmaceuticals N.V. reported a quarterly eps of 2.54 USD for 2024 Q1, up 1275.0% from previous quarter.
Cosmo Pharmaceuticals N.V. reported a quarterly eps of 0.10 USD for 2023 Q2, up 100.4% from previous quarter.

Annual Eps Chart of Cosmo Pharmaceuticals N.V. (2023 - 2004)

Historical Annual Eps of Cosmo Pharmaceuticals N.V. (2023 - 2004)

Year	Eps	Eps Growth
2023	-0.31 EUR	-91.54%
2022	1.14 USD	-25.0%
2021	1.52 USD	330.3%
2020	-0.66 USD	65.62%
2019	-1.92 USD	-36.17%
2018	-1.41 EUR	43.6%
2017	-2.50 EUR	-270.07%
2016	1.47 EUR	-92.17%
2015	18.77 EUR	266.6%
2014	5.12 EUR	6.44%
2013	4.81 EUR	241.13%
2012	1.41 EUR	166.04%
2011	0.53 EUR	112.0%
2010	0.25 EUR	-16.67%
2009	0.30 EUR	-55.88%
2008	0.68 EUR	7716.09%
2007	0.01 EUR	122.08%
2006	-0.04 EUR	-111.94%
2005	0.33 EUR	134.38%
2004	-0.96 EUR	0.0%

Year	Eps	Eps Growth
2024 Q2	2.52 USD	0.0%
2024 Q1	2.54 USD	1275.0%
2023 Q2	0.10 USD	100.4%
2023 FY	- USD	-91.54%
2023 Q4	-0.45 USD	-114.29%
2023 Q3	-0.21 USD	-310.0%
2023 Q1	0.05 USD	-91.82%
2022 FY	- USD	-25.0%
2022 Q4	0.61 USD	117.86%
2022 Q3	0.28 USD	-45.1%
2022 Q2	0.51 USD	0.0%
2021 FY	- USD	330.3%
2021 Q4	1.97 USD	0.0%
2021 Q2	-0.47 USD	0.0%
2020 Q2	-0.23 USD	0.0%
2020 FY	- USD	65.62%
2020 Q4	-0.41 USD	0.0%
2019 Q4	-0.29 USD	0.0%
2019 FY	- USD	-36.17%
2019 Q2	-1.63 USD	0.0%
2018 FY	- EUR	43.6%
2017 FY	- EUR	-270.07%
2016 FY	- EUR	-92.17%
2015 FY	- EUR	266.6%
2014 FY	- EUR	6.44%
2013 FY	- EUR	241.13%
2012 FY	- EUR	166.04%
2011 FY	- EUR	112.0%
2010 FY	- EUR	-16.67%
2009 FY	- EUR	-55.88%
2008 FY	- EUR	7716.09%
2007 FY	- EUR	122.08%
2006 FY	- EUR	-111.94%
2005 FY	- EUR	134.38%
2004 FY	- EUR	0.0%

Peer Eps Comparison of Cosmo Pharmaceuticals N.V.

Name	Eps	Eps Difference
AstraZeneca PLC	3.84 USD	108.073%
Bristol-Myers Squibb Company PFD CONV 2	3.88 USD	107.99%
CSPC Pharmaceutical Group Limited	0.07 USD	542.857%
Clarus Therapeutics Holdings, Inc.	-8.04 USD	96.144%
Novartis AG	7.63 USD	104.063%
PT Kalbe Farma Tbk.	0.00 USD	8048.718%